SandboxAQ Makes Advanced Drug Discovery Models Accessible Through Claude AI
📰 Original title: SandboxAQ brings its drug discovery models to Claude — no PhD in computing required
🤖 IA: It's not clickbait ✅
👥 Users: It's not clickbait ✅
View full AI summary: https://en.killbait.com/sandboxaq-makes-advanced-drug-discovery-models-accessible-through-claude-ai.html?utm_source=mastodon_world&utm_medium=social&utm_campaign=killbait.mastodon_world

SandboxAQ, a company founded as an Alphabet spinout about five years ago, is simplifying access to complex drug discovery and materials science models by integrating them into Anthropic's Claude AI platform. Traditionally, using SandboxAQ's large quantitative models (LQMs), which simulate molecular dynamics, quantum chemistry, and microkinetics, required specialized computing infrastructure. These models, grounded in physics rather than textual data patterns, allow researchers to predict how molecules will behave before conducting laboratory experiments, potentially saving time and billions in research costs. The new integration lets researchers interact with these advanced models using natural language through Claude, removing technical barriers and making cutting-edge tools more accessible to computational scientists, research scientists, and experimentalists at pharmaceutical and industrial companies. While other AI startups in the field have focused primarily on developing sophisticated models, SandboxAQ emphasizes usability, targeting scientists who need practical solutions for real-world challenges. This collaboration represents a shift toward democratizing high-level scientific AI, enabling users to access frontier quantitative models without the need for advanced computing expertise or extensive technical training. SandboxAQ has raised over $950 million and counts Eric Schmidt as chairman, underscoring its significant presence in AI-driven scientific research.
SandboxAQ Makes Advanced Drug Discovery Models Accessible Through Claude AI
📰 Original title: SandboxAQ brings its drug discovery models to Claude — no PhD in computing required
🤖 IA: It's not clickbait ✅
👥 Users: It's not clickbait ✅
View full AI summary: https://en.killbait.com/sandboxaq-makes-advanced-drug-discovery-models-accessible-through-claude-ai.html?utm_source=mastodon_social&utm_medium=social&utm_campaign=killbait.mastodon_social

SandboxAQ, a company founded as an Alphabet spinout about five years ago, is simplifying access to complex drug discovery and materials science models by integrating them into Anthropic's Claude AI platform. Traditionally, using SandboxAQ's large quantitative models (LQMs), which simulate molecular dynamics, quantum chemistry, and microkinetics, required specialized computing infrastructure. These models, grounded in physics rather than textual data patterns, allow researchers to predict how molecules will behave before conducting laboratory experiments, potentially saving time and billions in research costs. The new integration lets researchers interact with these advanced models using natural language through Claude, removing technical barriers and making cutting-edge tools more accessible to computational scientists, research scientists, and experimentalists at pharmaceutical and industrial companies. While other AI startups in the field have focused primarily on developing sophisticated models, SandboxAQ emphasizes usability, targeting scientists who need practical solutions for real-world challenges. This collaboration represents a shift toward democratizing high-level scientific AI, enabling users to access frontier quantitative models without the need for advanced computing expertise or extensive technical training. SandboxAQ has raised over $950 million and counts Eric Schmidt as chairman, underscoring its significant presence in AI-driven scientific research.
🤖 SandboxAQ Taps Claude for Drug Discovery Breakthrough
SandboxAQ's collaboration with Anthropic integrates its AI models into Claude, making drug discovery tools accessible without specialized infrastructure.
https://www.byte-pulse.net/article/sandboxaq-taps-claude-for-drug-discovery-breakthrough
Jack Hidary, CEO của SandboxAQ, dự đoán năm 2026 sẽ là bước ngoặt lớn cho trí tuệ nhân tạo với những đột phá mạnh mẽ. Các ứng dụng AI dự kiến bùng nổ trong y tế, giao thông và năng lượng, thúc đẩy chuyển đổi toàn cầu. #AI #ArtificialIntelligence #2026 #CôngNghệ #TríTuệNhânTạo #SandboxAQ #TươngLai
https://www.reddit.com/r/singularity/comments/1q4se6z/2026_will_be_an_explosive_year_for_al/